News

Zug - The cryptocurrency bank SEBA from the Greater Zurich Area has secured 110 million Swiss francs provided by investors from different parts of the world. The company hopes to use the fresh funds to drive international growth, focusing on Hong Kong, Singapore, and the Middle East, among other regions.

Dübendorf ZH - An Empa spin-off has integrated a self-learning algorithm into smart thermostats using a cloud-based solution. It is a peek into the future, regulating room temperature with foresight. This saves energy and ultimately money.

Schlieren ZH/Westmead - Genetic company DiNAQOR and the Children’s Medical Research Institute in Australia are joining forces to research novel cardiac-specific capsid variants. This enables gene therapies to be routed directly to the cardiac muscle.

Wetzikon ZH/Brunello - Reichle & De-Massari (R&M) has agreed a deal to acquire Tecnosteel, the Italian manufacturer of racks and enclosures for data centers. With this takeover, the cabling specialist from the Greater Zurich Area is aiming to offer infrastructure solutions for data centers from a single source in future.

Zurich - Xlife Sciences has drawn up plans for a listing in the new “Sparks” segment of the SIX Swiss Exchange for SMEs in the first quarter of 2022. At present, the company with a focus on the further development of promising life sciences technologies is listed on the Munich Stock Exchange.

Schlieren ZH - The efficacy of ensovibep, a COVID-19 drug developed by Molecular Partners, has been confirmed as part of a Phase 2 study. Novartis will now seek to secure exclusive licensing rights. Molecular Partners will receive a one-off payment of 150 million Swiss francs and retain royalty rights of 22 percent of ensovibep sales.

Amsterdam - Swiss start-ups banked a total of 3.1 billion US dollars in venture capital from investors last year. As such, the total value of the Swiss start-up ecosystem has increased by a factor of 3.7 since 2016. Moreover, Switzerland yields more start-ups per capita than its neighboring countries.

Schlieren ZH - Neurimmune has entered into a collaboration and license agreement with the AstraZeneca subsidiary Alexion for the development and marketing of the cardiovascular medication NI006. Neuroimmune will receive an upfront payment of 30 million US dollars with the potential for additional payments contingent on the achievement of milestones of up to 730 million US dollars.

Zug/Maranello - Ferrari is joining forces with the Zug-based start-up Velas Network. As part of this link-up, Velas Network will develop digital content on the basis of blockchain technology for the luxury Italian automotive manufacturer. This content is intended to appeal to fans of the Scuderia motorsport division.